155 related articles for article (PubMed ID: 34488398)
1. Long-term follow-up of 46 cases of primary fallopian tube carcinoma: a single institute study.
Li S; Yu M; Bai W; Shi J; Di W
Ann Palliat Med; 2021 Aug; 10(8):9122-9135. PubMed ID: 34488398
[TBL] [Abstract][Full Text] [Related]
2. Unexpected primary fallopian tube carcinoma during gynecological operations: Clinicopathological and prognostic factors analyses of 67 cases.
Sun M; Bao L; Shen H; Ji M; Yao L; Yi X; Jiang W
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):626-632. PubMed ID: 31542083
[TBL] [Abstract][Full Text] [Related]
3. Primary fallopian tube carcinoma--a retrospective analysis of 66 cases.
Liu L; Xu X; Jia L; Wei M; Qian B; Wu Y; Shen Y; Wang X; Pei H; Chen X
Eur J Gynaecol Oncol; 2015; 36(2):161-7. PubMed ID: 26050354
[TBL] [Abstract][Full Text] [Related]
4. Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
Bao L; Ding Y; Cai Q; Ning Y; Hu W; Xue X; Sun H; Hua K; Zhou X; Yi X
Int J Gynecol Cancer; 2016 Mar; 26(3):424-30. PubMed ID: 26825825
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of primary Fallopian tube carcinoma: A single-institution retrospective study of 57 cases.
Ma Z; Gao L; Li H; Li J; Zhang G; Xue Y
Int J Gynaecol Obstet; 2021 Jun; 153(3):405-411. PubMed ID: 33230808
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of primary fallopian tube cancer in a single institute in Taiwan.
Horng HC; Teng SW; Lai CR; Chang WH; Chang YH; Yen MS; Wang PH
Int J Gynaecol Obstet; 2014 Oct; 127(1):77-81. PubMed ID: 24997471
[TBL] [Abstract][Full Text] [Related]
7. Primary fallopian tube cancer: domestic data and up-to-date review.
Horng HC; Teng SW; Huang BS; Sun HD; Yen MS; Wang PH; Tsui KH; Wen KC; Chen YJ; Chuang CM; Chao HT; Chang WH
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):287-92. PubMed ID: 25286779
[TBL] [Abstract][Full Text] [Related]
8. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas.
Horng HC; Lai CR; Chang WH; Wen KC; Chen YJ; Juang CM; Yen MS; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699
[TBL] [Abstract][Full Text] [Related]
9. Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma.
Ma Y; Duan W
World J Surg Oncol; 2014 Oct; 12():311. PubMed ID: 25307473
[TBL] [Abstract][Full Text] [Related]
10. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
11. Primary fallopian tube carcinoma: a clinicopathologic analysis and literature review.
Lau HY; Chen YJ; Yen MS; Chen RF; Yeh SO; Twu NF
J Chin Med Assoc; 2013 Oct; 76(10):583-7. PubMed ID: 23890835
[TBL] [Abstract][Full Text] [Related]
12. HE4 is associated with clinical risk prognostic factors and survival outcome in primary fallopian tube carcinoma patients.
Mi D; Zhang Y; Chen S
J Obstet Gynaecol Res; 2022 Jul; 48(7):1897-1903. PubMed ID: 35596602
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
[No Abstract] [Full Text] [Related]
14. Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy.
Kietpeerakool C; Srisomboon J; Phongsaranantakul S; Khunamornpong S; Cheewakriangkrai C; Sribanditmongkol N
J Obstet Gynaecol Res; 2014 Mar; 40(3):806-11. PubMed ID: 24738123
[TBL] [Abstract][Full Text] [Related]
15. [Residual Disease Status after Primary Cytoreductive Surgery in Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Carcinoma and Long-Term Progression-Free Survival].
Otsuka I; Matsuura T
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2547-2551. PubMed ID: 28028263
[TBL] [Abstract][Full Text] [Related]
16. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
17. Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinoma.
McEachron J; Zhou N; Hastings V; Bennett M; Gorelick C; Kanis MJ; Lee YC
Cancer Treat Res Commun; 2022; 33():100631. PubMed ID: 36096033
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study.
Hefler LA; Rosen AC; Graf AH; Lahousen M; Klein M; Leodolter S; Reinthaller A; Kainz C; Tempfer CB
Cancer; 2000 Oct; 89(7):1555-60. PubMed ID: 11013371
[TBL] [Abstract][Full Text] [Related]
19. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
[TBL] [Abstract][Full Text] [Related]
20. Primary fallopian tube carcinoma - the experience of a UK cancer centre and a review of the literature.
Clayton NL; Jaaback KS; Hirschowitz L
J Obstet Gynaecol; 2005 Oct; 25(7):694-702. PubMed ID: 16263546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
